Items where Author is "Creaser, C"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 11.

Journal article

BOATENG, J., KAY, R., LANCASHIRE, L., BROWN, P., VELLOSO, C., BOULOUX, P., TEALE, P., ROBERTS, J., REES, R., BALL, G., HARRIDGE, S., GOLDSPINK, G. and CREASER, C., 2009. A proteomic approach combining mass spectrometric and bioinformatics analysis for the detection and identification of biomarkers of administration of exogenous human growth hormone in humans. Proteomics - Clinical Applications, 3 (8), pp. 912-922. ISSN 1862-8346

MATHAROO-BALL, B., HUGHES, C., LANCASHIRE, L., TOOTH, D., BALL, G., CREASER, C., ELGASIM, M., REES, R., LAYFIELD, R. and ATIOMO, W., 2007. Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms. Journal of Proteome Research, 6 (8), pp. 3321-3328. ISSN 1535-3893

MATHAROO-BALL, B., HUGHES, C., LANCASHIRE, L., TOOTH, D., BALL, G., CREASER, C., ELGASIM, M., REES, R.C., LAYFIELD, R. and ATIOMO, W., 2007. Combinational proteomic characterization of biomarkers in polycystic ovary syndrome (PCOS). Journal of Proteome Research, 6 (8), pp. 3321-3328.

BOATENG, J., LANCASHIRE, L., BROWN, P., AHMAD, M., MATHAROO-BALL, B., DAVY, R., YANG, S.Y., ROBERTS, J., TEALE, P., VELLOSO, C., REES, R., BALL, G., GOLDSPINK, G. and CREASER, C., 2006. The use of proteomic and bioinformatics techniques for the detection of protein biomarkers following growth hormone administration. The Internet Journal of Genomics and Proteomics, 2 (2). ISSN 1540-2630

WESTON, D.J., BATEMAN, R., WILSON, I.D., WOOD, T.R. and CREASER, C., 2005. Direct analysis of pharmaceutical drug formulations using ion mobility spectrometry/quadrupole-time-of-flight mass spectrometry combined with desorption electrospray ionization. Analytical Chemistry, 77 (23), pp. 7572-7580. ISSN 0003-2700

MIAN, S., UGUREL, S., PARKINSON, E., SCHLENZKA, I., DRYDEN, I., LANCASHIRE, L., BALL, G., CREASER, C., REES, R. and SCHADENDORF, D., 2005. Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. Journal of Clinical Oncology, 23 (22), pp. 5088-5093. ISSN 0732-183X

LANCASHIRE, L., UGUREL, S., CREASER, C., SCHADENDORF, D., REES, R. and BALL, G., 2005. Utilizing artificial neural networks to elucidate serum biomarker patterns which discriminate between clinical stages in melanoma. Proceedings of the 2005 Ieee Symposium on Computational Intelligence in Bioinformatics and Computational Biology, pp. 455-460.

MIAN, S., BALL, G., HORNBUCKLE, J., HOLDING, F., CARMICHAEL, J., ELLIS, I., ALI, S., LI, G., MCARDLE, S.E., CREASER, C. and REES, R., 2003. A prototype methodology combining surface-enhanced laser desorption/ionization protein chip technology and artificial neural network algorithms to predict the chemoresponsiveness of breast cancer cell lines exposed to Paclitaxel and Doxorubicin under in v. Proteomics, 3 (9), pp. 1725-1737.

CREASER, C., DOS, S., LAMARCA, D.G., NEW, A. and WOLFF, J.C., 2002. Biodegradation studies of 4-fluorobenzoic acid and 4-fluorocinnamic acid: an evaluation of membrane inlet mass spectrometry as an alternative to high performance liquid chromatography and ion chromatography. Analytica Chimica Acta, 454 (1), pp. 137-145. ISSN 0003-2670

DODI, I.A., RUSAKIEWICZ, S., AUBERT, G., CLARKE, R., CHRISTMAS, S., CREASER, C., BONNER, P., REES, R., TRAVERS, P.J. and MADRIGAL, J.A., 2002. Definition of the breakpoint fusion peptides for HLA-A3 and HLA-B8 in CML cells. Tissue Antigens, 59, p. 45. ISSN 0001-2815

BALL, G., MIAN, S., HOLDING, F., ALLIBONE, R.O., LOWE, J., ALI, S., LI, G., MCCARDLE, S., ELLIS, I.O., CREASER, C. and REES, R.C., 2002. An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics, 18 (3), pp. 395-404. ISSN 1367-4803

This list was generated on Sun Nov 28 18:44:34 2021 UTC.